Anda di halaman 1dari 33

Coagulation Disorders

International

Gangguan Koagulasi
Dalam Kehamilan
Coagulation Disorders
International

Objektif :
• Definisi
• Penyebab
• Patofisiologi
• Gambaran klinis
• Diagnosis
• Tatalaksana
Coagulation Disorders
International

Hemostasis Koagulasi

• Kemampuan alami tubuh untuk menghentikan perdarahan


melalui koordinasi endotel pembuluh darah, adhesi trombosit
dan keterlibatan aktif faktor koagulasi.

• Fungsi utama mekanisme koagulasi adalah menjaga keenceran


darah sehingga darah dapat mengalir dalam sirkulasi dengan
baik, serta membentuk thrombus sementara (hemostatik
thrombus) pada dinding pembuluh darah yang mengalami
kerusakan (vascular injury).
Coagulation Disorders
International

Hemostasis Koagulasi

Komponen utama hemostasis yaitu : trombosit, endotel vaskular,


procoagulant plasma protein factors, natural anticoagulant
proteins, protein fibrinolitik dan protein antifibrinolitik.

Interaksi antar komponen dapat memicu :


• trombosis disebut sebagai sifat protrombotik
• menghambat proses trombosis yang berlebihan, disebut
sebagai sifat antitrombotik.
Coagulation Disorders
International

Hemostasis Koagulasi

Hemostasis normal dapat dibagi menjadi dua tahap:


yaitu hemostasis primer dan hemostasis sekunder.

Proses koagulasi berlangsung melalui dua jalur, yaitu


jalur ekstrinsik (extrinsic pathway) dan jalur intrinsik
(intrinsic pathway).
Coagulation Disorders
International

Jalur Koagulasi
• Jalur ekstrinsik dimulai jika terjadi kerusakan vaskuler
mengakibatkan pelepasan (paparan) faktor jaringan (tissue
factor) ke dalam sirkulasi. Jalur ekstrinsik berlangsung pendek
karena dihambat oleh tissue factor pathway inhibitor (TFPI).

• Jalur intrinsik dimulai dengan adanya kontak aktivasi yang


melibatkan faktor XII yang kemudian mengaktifkan faktor IX
menjadi faktor IXa
Coagulation Disorders
International
Coagulation Disorders
International

Definisi

Koagulasi abnormal

• konsumtif :
disseminated intravascular coagulation (DIC)
peningkatan fibrinolisis dan fibrin split products

• dilusional :
sekunder akibat penggantian volume cairan tubuh yang masif
kristaloid atau PRBC tanpa faktor-faktor pembekuan
Coagulation Disorders
International

Penyebab - Konsumtif
• Solusio plasenta
• Preeklamsia / Eklamsia
• Sepsis - termasuk abortus septik
• Emboli cairan ketuban
• Kematian janin intrauterin
• Penyakit trofoblastik
Coagulation Disorders
International

Penyebab - Dilusi

Resusitasi cairan yang masif karena hipovolemia


• post-partum hemorrhage
• solusio plasenta
• plasenta previa
• ruptura uterine
• kehamilan ektopik / abortus inkomplt
• perdarahan bukan dari kehamilan
Coagulation Disorders
International

Aktivasi Sistem Pembekuan

• Pelepasan tromboplastin (TF)


- Akut : solusio plasenta, emboli ketuban, ruptura uteri
- Subakut : IUFD, missed abortion
• Kerusakan endotel
- preeklamsia, sepsis
• Destruksi jaringan : ruptura uteri
• Pelepasan fosfolipid : sepsis, reaksi transfusi
Coagulation Disorders
International
Coagulation Disorders
International

Gambaran Klinis
• Tanda dan gejala penyebab utama
• Manifestasi perdarahan :
- peteki, memar, epistaksis
- operative sites, perdarahan postpartum
• hipotensi dan hipoperfusi
Coagulation Disorders
International

Diagnosis

• Kenali tanda-gejala pencetus


• Kadar trombosit turun
• Pemanjangan PT dan APTT
• Kadar fibrinogen turun
• Peningkatan fibrin split products
• Hapus darah tepi – kerusakan eritrosit
Coagulation Disorders
International

PT - APTT
• Pemeriksaan PT (prothrombin time) digunakan untuk
menilai kemampuan faktor koagulasi jalur ekstrinsik dan
jalur bersama. PT memanjang karena defisiensi faktor
koagulasi ekstrinsik dan bersama.

• Pemeriksaan APTT (activated partial thromboplastin time,


APTT) menilai aktifitas faktor koagulasi jalur intrinsik dan
jalur bersama. APTT memanjang karena defisiensi faktor
koagulasi instrinsik dan bersama.
Coagulation Disorders
International

Tatalaksana – Prinsip

• kondisi cepat berkembang dan berubah


• hasil lab mungkin tidak merefleksikan situasi
terkini
• serius ancaman jiwa
• terapi cepat dan rasional
• pendekatan interdisiplin
Coagulation Disorders
International

Tatalaksana – Inisiasi Penyebab Utama

• Identifikasi cepat penyebab utama


• Terapi adekuat
• Hilangkan penyebab
 allows homeostatic mechanisms to recover
Coagulation Disorders
International

Tatalaksana – Resusitasi
• Oksigen
• Jaga perfusi organ
– cegah iskemi organ - hepar, ginjal
– sintesis faktor-faktor pembekuan
• Infusi kristaloid cepat - saline, Ringer
• Tranfusi komponen darah - indikasi
Coagulation Disorders
International

Tataksana - Procoagulant Replacement

• Tranfusi komponen – situasi khusus


– Fresh whole blood
– Fresh Frozen Plasma
– Cryoprecipitate
– Platelets
• Tatalaksana bersama ahli hematologi
• Antikoagulan bukan keharusan
Coagulation Disorders
International

Replacement of procoagulants

• Fresh frozen plasma replaces most clotting factors.


1 unit after the initial 4-6 units of whole blood and thereafter 1 unit for
every 2 units of wholeblood required.

• Cryoprecipitates may be necessary if fibrinogen levels are low.

• Platelets can be transfused in severe cases of thrombocytopenia.


1 unit of platelets can raise the number of platelets to about
5000-10.000.
Coagulation Disorders
International

Simpulan
• Identifikasi dan terapi penyebab utama
• Resusitasi cepat
• oksigen
• penggantian volume cairan
• tranfusi RBC
• Tranfusi clotting factor
• Pendekatan multidisiplin
Coagulation Disorders
International

TERIMA KASIH
Coagulation Disorders
International

Inhibition of the DIC and fibrinolysis

The use of heparin has been advocated as a method of blocking DIC.


It is especially recommended in cases of chronis DIC, as is the intrauterine
death syndrome. It is not recommended if the patient is bleeding profusely.

Epsilon aminocaproic acid (EACA) inhibits the conversion of plasminogen


to plasmin and its use has been suggested as a means to counteract
secondary fibrinolysis. It is not recommended in these cases.
Coagulation Disorders
International
Coagulation Disorders
Quality of
Management option
International Strength of recommendation
evidence
DIC/massive Interdisciplinary approach IV C
hemorrhage (Obstetrics/hematology)
Treat cause IV C

Resuscitation volume IV C
replacement to maintain
tissue perfusion
Replace fresh frozen IV C
plasma, cryoprecipitate and
platelets on basis of
laboratory results and
clinical condition
Consider heparin in severe IV C
DIC due to amniotic fluid
embolism
Acquired inhibitors of Interdisciplinary approach IV C
coagulation (obstetrics/hematology)
Specific clotting factor IV C
concentrates (individualized
management) III B
Immunosuppressive therapy IV C
III B
Coagulation Disorders
International

Disseminated intravascular coagulation


Strength of
Management option Quality of evidence
recommendation
Involve hematologist and support
- √
services (blood transfusion etc.) early
Treat/remove cause (e.g.empty uterus, - √
antibiotics for sepsis)
Hematological priorities are to replace
blood constituents and coagulation III B
factors
Heparin and antithrombolytic therapy
have both been used in DIC to break the
cycle of consumptive coagulopathy. IV C
Neither has been subjected to controlled
trials
Coagulation Disorders
International
Coagulation Disorders
International
Coagulation Disorders
International
Coagulation Disorders
International
THROMBOPHILIA
D-DIMER DIAGRAM
Coagulation Disorders
International
Coagulation Disorders
International
Coagulation Disorders
International
TABLE – Couses and Pathophysiology of
Disseminated Intravascular Coagulation

Anda mungkin juga menyukai